Experiences with
Imbruvica843 public posts
Want to take advantage of all our features? Just log in!
or
CLL Treatment Sequencing by Dr. Susan O'Brien
O'Brien, MD
Chemotherapy is becoming less of a priority in the treatment paradigm of chronic lymphocytic leukemia (CLL) with the addition of the FDA-approved novel agents ibrutinib (Imbruvica), idelalisib (Zydelig), and venetoclax (Venclexta), explained Susan M. O’Brien, MD.
CAR T-Cell Developments in Lymphoma Dr. Ian Flinn Highlights
.
-
One last publication to think about is the data we've seen involving Waldenström macroglobulinemia where rituximab was compared with the combination of ibrutinib (Imbruvica) and rituximab.